Deletion of CISH in iPSC-derived NK [51] or cord blood-derived NK [52] resulted in increased JAK/STAT signalling and mTORC1 signalling leading to increasing NK cell metabolic fitness that directly contributed to improved anti-tumour responses [51, 53]. This evidence concerns the gene CISH and neoplasm.